Adam S Komorowski

15PUBLICATIONS
39CO-AUTHORS
Medical infection agents (incl. prions)Medical bacteriologyGreenhouse gas inventories and fluxesPredictive and prognostic markersInfectious agents
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 06, 2026
Daptomycin and linezolid salvage therapy for persistent ampicillin-susceptible Enterococcus faecalis bacteremia in a patient with possible anaphylaxis to β-lactam and glycopeptide antimicrobials: A case report.

|Aug 19, 2025
Molecular Epidemiology of Clinical Infections Caused by Serratia marcescens Complex in a Tertiary Care Hospital System: Insights From Whole-Genome Sequencing.

Adam S Komorowski, Michael G Surette, Laura Rossi

|Jun 10, 2025
AeroVax: study protocol for a randomised, double-blind, placebo-controlled, phase 2 trial to evaluate safety and immunogenicity of a next-generation COVID-19 vaccine delivered by inhaled aerosol to humans.

Adam S Komorowski, Lawrence Mbuagbaw, Mangalakumari Jeyanathan

|Apr 26, 2025
The Impact of Beta Blockers on Survival in Cancer Patients: A Systematic Review and Meta-Analysis.

Alisha E Sharma, Stephanie Chan, Adam S Komorowski

|Jun 18, 2024
Verification, Analytical Sensitivity, Cost-effectiveness, and Comparison of 4 Candida auris Screening Methods.

Adam S Komorowski, Patryk Aftanas, Vanessa Porter

|Jan 24, 2024
Evaluating in vivo effectiveness of sotrovimab for the treatment of Omicron subvariant BA.2 versus BA.1: a multicentre, retrospective cohort study.

Carson K L Lo, Calvin K F Lo, Adam S Komorowski

Pageof 3

Frequent Collaborators

8 joint publications

Anthony D Bai

4 joint publications

Carson K L Lo

4 joint publications

Dominik Mertz

3 joint publications

Xena X Li